European Society for Radiotherapy and Oncology (ESTRO)

🎓 Reirradiation Webinar Series | Session 2: Paediatric Re-irradiation Join us for the second session of the Reirradiation Webinar Series, where leading experts will share insights on best practices and emerging solutions in paediatric re-irradiation. 🔹 Chair: Heidi S. Rønde (DK), Medical Physicist, Danish Centre for Particle Therapy, Aarhus University Hospital 🔹 Co-chair: Bianca Hoeben (NL), Department of Radiation Oncology, University Medical Center Utrecht 🗣️Speakers: - Professor Thankamma Ajithkumar (UK), Consultant Clinical Oncologist, Cambridge University Hospitals - Professor Marianne Aznar (UK), Radiation Oncology Physicist, University of Manchester 🔵This session will address current challenges and future directions in paediatric radiotherapy, including insights from the PENTEC and ReCOG groups. Topics will cover re-irradiation, image registration in growing children, and the use of automatic tools to support safe treatment delivery. 👉More info on the webinar series here: here: https://bit.ly/4huhiBK 🔗Register here: https://bit.ly/47kPmvv 📧 For support please contact: [email protected] #ESTRO #ReirradiationSeries #Radiotherapy #PaediatricOncology #MedicalPhysics #OncologyEducation #RadiationOncology

Comparison of survival and progression after focal- or whole brain radiotherapy in patients with primary CNS lymphoma: results from a large multicenter analysis published in the Radiotherapy and Oncology. 👉 Read it before your patients: https://bit.ly/46TgaEg

📢Register for Physics for Modern Radiotherapy | Online Course 📅 3–7 November 2025 💻 Online Deepen your understanding of how radiotherapy works — from dose delivery and treatment planning to QA and risk management. Ideal for: 🎯 Trainees, early-career oncologists & physicists 🎯 Clinicians, dosimetrists & technologists eager to update their technical knowledge Join international experts to explore the physics and principles behind modern radiotherapy. 👉 Register now: https://bit.ly/4o9WMc8 #ESTRO #Radiotherapy #MedicalPhysics #RadiationOncology #ESTROSchool25 #OncologyEducation

Your voice matters for radiotherapy safety! 🙌 Complete our short survey on reporting & learning practices. Your input will help improve ROSEIS and make procedures safer for patients. 📆 Participation deadline: 7 November 2025 👉 Take the survey here: http://bit.ly/4gLbZgO ROSEIS: Radiation Oncology Safety Education and Information System petra reijnders Mary Coffey Aude Vaandering Daniela Sandu

🏆 Travel Grant Award Report – Wolfsberg 2025 ⚡ Radioresistance was a key topic at the Wolfsberg Meeting. Presentations highlighted diverse mechanisms — from metabolism and DNA repair to senescence — that offered new perspectives on why some cancers respond less well to radiotherapy treatment than others. 👉 https://bit.ly/4q7KyC3 Ilaria Colauzzi #Radiotherapy #Radioresistance #Radiobiology #CancerResearch #WolfsbergMeeting

📢Assisi Think-Tank Meeting on Breast Cancer | Endorsed by ESTRO The 6th Assisi Think-Tank Meeting (ATTM) on Breast Cancer will take place on 📅 5–7 February 2026, the European Society of Breast Cancer Specialists, and the Italian Association of Radiotherapy and Clinical Oncology. 📃Designed as a brainstorming project, the ATTM gathers leading European experts in radiation and clinical oncology to address contemporary challenges in breast cancer care through focused presentations and in-depth discussions. We warmly invite all professionals interested in breast cancer management, whether experienced or in training, to join this collaborative and forward-thinking meeting. ℹ️Learn more and register: https://bit.ly/3WOmdnp #BreastCancer #Oncology #Radiotherapy #Research #ESTRO #AssisiThinkTank #CancerCare

📣 Join the ESTRO Biology Committee! ESTRO is looking for 2️ members to join its Biology Committee — a dynamic team working to strengthen and promote biology within the radiotherapy community. 📆 Deadline: 10 December 2025 ℹ More information 👉 https://bit.ly/4ne8mS4 ✅ Apply now! 👉 https://bit.ly/4qDD4Y7 Heidi Lyng #RadiationOncology #Radiotherapy #Radiobiology

Elderly patients with head & neck squamous cell carcinoma remain underrepresented in clinical trials — leaving clinicians with limited evidence to guide treatment decisions. ✅ We invite you to share your clinical experience to help us capture current practice patterns across Europe. Your input will play a key role in shaping future research priorities and treatment recommendations. 📍 Focus: squamous cell malignancies of the oro-/hypopharynx, larynx, and oral cavity 🕒 Time: ~10 minutes 🔒 Fully anonymous 👉 Take the survey: http://bit.ly/46snipr Jon Cacicedo Fernandez de Bobadilla Nils Nicolay #HeadAndNeckCancer #Radiotherapy #ESTROsurvey #CancerCare

Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index: a randomised phase 3 trial published in The Lancet. 👉 Read it before your patients: https://bit.ly/42Hvh0R The Lancet Group

🏆 Travel Grant Award Report – Wolfsberg 2025 Can low-dose CT radiation influence colon cancer risk? A poster at the Wolfsberg Meeting explored how effects may vary with the stage of carcinogenesis and genetic background. 👉 https://bit.ly/3KW8HLT Mélissandre Gomot #Radiobiology #CancerResearch #coloncancer #Radiotherapy